aminocaproic acid has been researched along with Esophageal Neoplasms in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grover, N | 1 |
| Johnson, A | 1 |
| Bespalov, VG | 1 |
| Aleksandrov, VA | 1 |
| Petrov, AS | 1 |
| Troian, DN | 1 |
2 other studies available for aminocaproic acid and Esophageal Neoplasms
| Article | Year |
|---|---|
Aminocaproic acid used to control upper gastrointestinal bleeding in radiation gastritis.
Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Esophageal Neoplasms; Gastritis; Gastrointestinal | 1997 |
[The inhibiting effect of epsilon-aminocaproic acid on the incidence of induced tumors of the esophagus, nervous system and kidneys].
Topics: Aminocaproic Acid; Animals; Anticarcinogenic Agents; Carcinogens; Chi-Square Distribution; Dimethyln | 1992 |